Sara J Mcelroy is a Tampa, Florida based nurse practitioner. Active license number of Sara J Mcelroy is APRN11020390 in Florida. Her current practice location is 12902 Usf Magnolia Dr, Tampa. Patients can reach her at 813-745-4673 or can fax her at 813-449-8618. Sara J Mcelroy is DNP, APRN, FNP-BC and her NPI number (Unique professional ID assigned by NPPES) is 1881301570. Sara J Mcelroy has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Sara J Mcelroy speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1881301570
NPI Enumeration Date:
01 Nov, 2022
NPI Last Update On:
25 Mar, 2025
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Sara J Mcelroy are as mentioned below.
License Number
Specialization
State
Status
APRN11020390
Florida
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Sara J Mcelroy Po Box 198441, Atlanta, Georgia
Zip:
30384-8441
Phone Number:
813-745-4673
Fax Number:
813-449-8618
Patients can reach Sara J Mcelroy at 12902 Usf Magnolia Dr, Tampa, Florida or can call to book an appointment on 813-745-4673.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 June, 2025.